16:48 EST Moleculin Biotech (MBRX) files to sell 2.61M shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech Amends Warrants to Boost Nasdaq Compliance
- Buy Rating for Moleculin Biotech: Promising Progress with WP1066 in Pediatric Brain Tumors
- Moleculin Biotech Reports Positive Phase 1 Trial Results
- Moleculin Biotech announces results from Phase 1 trial of WP1066
- Moleculin Biotech Regains Nasdaq Compliance